Experimental Tobacco Marketplace
Study Description
“Electronic Cigarette Unit Price Manipulations in the Experimental Tobacco Marketplace”
Electronic cigarettes (e-cigarettes) may be a safer alternative to conventional cigarettes and are available in a broad range of nicotine strengths. The overall goal of this project is to use an experimental analogue of the real-world tobacco marketplace to examine the effects of nicotine strength on e-cigarette consumption and the likelihood that current smokers will either switch to e-cigarettes (which may reduce harm) or use both products in combination (which may increase harm). Testing effects of e-cigarette nicotine strength under controlled conditions in a context that models the real world will facilitate evidence-based policies that have a net benefit to health.
Location
Methods
Pharmaceutical medication involved
Patients and healthy individuals accepted
Drug - 3 mg/mL nicotine strength e-liquid
Availability of 3 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace
Drug - 6 mg/mL nicotine strength e-liquid
Availability of 6 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace
Drug - 12 mg/mL nicotine strength e-liquid
Availability of 12 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace
Drug - 24 mg/mL nicotine strength e-liquid
Availability of 24 mg/mL nicotine strength e-liquid in the Experimental Tobacco Marketplace
Additional Information
Official Study Title
Effects of Electronic Cigarette Unit Price Manipulations in the Experimental Tobacco Marketplace on Tobacco Product Substitution
Clinical Trial ID
NCT03843047
ParticipAid ID
eZ6X2e
